August 1, 2011
Medifast Introduces New 5-Calorie Pre-Measured Sugar-Free Syrup
OWINGS MILLS, Md., Aug. 1, 2011 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading portion-controlled weight-loss program, today announced the launch of 5-calorie pre-measured Medifast Sugar-Free Syrup. Medifast Sugar-Free Syrup is the perfect addition to many Medifast Meals, including the new Medifast Spiced Pancakes. New products are available for purchase at http://www.choosemedifast.com/, through a free Take Shape For Life Health Coach or at a Medifast Weight Control Center.
"We noticed our customers often asking about a low-calorie and sugar-free syrup to add to their Medifast Meals, so we developed our new Sugar-Free Syrup to increase success on the program and provide a one-stop shopping option," said Michael S. McDevitt, Chief Executive Officer, Medifast, Inc. "The goal is to provide customers with all the tools necessary to provide long-term weight loss and weight maintenance."
Medifast Sugar-Free Syrup counts as two condiments for those currently on the Medifast 5 & 1 Plan, while Medifast Spiced Pancakes are completely interchangeable with other Medifast Meals on the Medifast 5 & 1 Plan. Medifast has been recommended by over 20,000 doctors since 1980. Customers can expect to lose up to two to five pounds per week and up to 20 pounds their first month on the Medifast 5 & 1 Plan, in which customers eat five Medifast Meals and one Lean & Green Meal, consisting of lean protein and non-starchy vegetables, each day.
"Medifast's newest products are based on our research exploring customer preferences. People on the Medifast 5 & 1 Plan or in Transition or Maintenance will love our new, naturally sweetened Spiced Pancakes, especially with our new syrup," said Lisa M. Davis, Ph.D., PA-C, C.N.S., L.D.N., Vice President of Scientific and Clinical Affairs, Medifast, Inc. "New products like these reflect our dedication to our clients, and our ability to give them what they need and want."
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. Medifast has been recommended by over 20,000 doctors and used by over one million customers since 1980. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com.
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
SOURCE Medifast, Inc.